Pharmalot By Ed Silverman Corporate private eyes accuse Glaxo of taking actions that led to their imprisonment
Pharmalot By Ed Silverman Which drug makers do a good job getting poor patients access to their medicines?
Pharmalot By Ed Silverman Pharmalot, Pharmalittle: Glaxo CEO looks for drug prices to fall no matter who is president
Pharmalot By Ed Silverman What clinical trial results? Now you can see who isn’t sharing their findings
Pharmalot By Ed Silverman Pharmalot, Pharmalittle: Glaxo believes its plan for HIV treatment is a ‘game changer’
Business By Rebecca Robbins A popular weight-loss pill was buoyed by studies that understated its harms
Pharmalot By Ed Silverman Q&A: Glaxo exec says bioelectronics venture with Verily is ‘not science fiction’
Business By Stephanie Simon Google spinoff teams with pharma giant to treat disease by zapping nerves
Pharmalot By Ed Silverman Pharmalot, Pharmalittle: Brexit, schmexit. Glaxo invests $360 million in the UK
Pharmalot By Ed Silverman Former Glaxo scientists and the feds fight over reviewing allegedly stolen documents
Pharmalot By Ed Silverman Supreme Court says Glaxo must face racketeering lawsuits over a diabetes pill